MarkClydeGebhardtMD

Musculoskeletal Oncology/Cancer, Pediatric Orthopedics

Frederic W. and Jane M. Ilfeld Professor of Orthopedic Surgery, Beth Israel Deaconess Medical Center

Dr. Gebhardt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
330 Brookline Ave
# Bidmc
Boston, MA 02215
Phone+1 617-667-2140

Fax+1 617-667-0227

Dr. Mark Gebhardt is an orthopedic surgeon in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Massachusetts General Hospital, and Dartmouth-Hitchcock Medical Center. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 42 years. He specializes in musculoskeletal oncology/cancer and pediatric orthopedics and is experienced in musculoskeletal oncology and pediatric orthopaedics.

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Orthopaedic Surgery, 1978 - 1981
UPMC Medical Education (Pittsburgh)Residency, Surgery, 1975 - 1977
University of Cincinnati College of MedicineClass of 1975

PubMed

151 citations
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development : Meeting summary
Richard Gorlick, Peter M. Anderson, Irene L. Andrulis, Carola A.S. Arndt, G. Peter Beardsley
Clinical Cancer Research. 2003-11-15
2005 citations
A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.
William F. Enneking, William K. Dunham, Mark C. Gebhardt, Martin Malawar, Douglas J. Pritchard
Clinical Orthopaedics and Related Research. 1993-01-01
302 citations
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, in...
Neyssa Marina, Sigbjørn Smeland, Stefan S. Bielack, Mark L. Bernstein, Gordana Jovic
The Lancet. Oncology. 2016-10-01

Other

Osteosarcoma: Epidemiology, pathogenesis, clinical presentation, diagnosis, and histology
Gebhardt MC, Wang LL, Chintagumpala M
http://www.uptodate.com/contents/osteosarcoma-epidemiology-pathogenesis-clinical-presentation-diagno
UpToDate, Wolters Kluwer Health - 2012-05-31
Treatment of the Ewing sarcoma family of tumors
Gebhardt MC, Harmon DC
http://www.uptodate.com/contents/treatment-of-the-ewing-sarcoma-family-of-tumors
UpToDate, Wolters Kluwer Health - 2012-12-11
Local treatment for primary soft tissue sarcoma of the extremities and chest wall
Gebhardt MC, Harmon DC, DeLaney TF
http://www.uptodate.com/contents/local-treatment-for-primary-soft-tissue-sarcoma-of-the-extremities-
UpToDate, Wolters Kluwer Health - 2013-04-10
Treatment of locally recurrent and unresectable, locally advanced soft tissue sarcoma of the extremities
Gebhardt MC, Harmon DC, DeLaney TF
http://www.uptodate.com/contents/treatment-of-locally-recurrent-and-unresectable-locally-advanced-so
UpToDate, Wolters Kluwer Health - 2013-01-18
Join now to see all

Generations of Excellence in Caring for Childhood Bone Cancers: Dr. Gebhardt and Dr. AndersonDecember 9th, 2021
TheFace: Sara Almoosa, Saudi Marketing DirectorJanuary 10th, 2020
Beware of Studies Claiming That Social Factors Are “Independently Associated” with Biological Complications of SurgerySeptember 16th, 2019
Join now to see all